Chan Zuckerberg Initiative

Investment Strategy

The Chan Zuckerberg Initiative was founded in 2015 by Mark Zuckerberg, the co-founder and CEO of Meta Platforms, and his wife Priscilla Chan, a pediatrician and educator. At its launch, Zuckerberg and Chan pledged to give away 99% of their Meta shares over their lifetimes to advance human potential and promote equality. At current market valuations, this pledge represents one of the largest philanthropic commitments in history, exceeding $50 billion in total value.

CZI is structured as a limited liability company, a deliberate choice that provides maximum flexibility in how capital is deployed. Unlike a private foundation, CZI can make for-profit investments, fund political campaigns, engage in lobbying, and issue grants, all from the same entity. The organization currently manages an estimated $3 billion in endowment assets, with additional Meta shares being transferred over time as Zuckerberg executes the planned share donation.

The organization’s work spans three areas: science, education, and community and justice. In science, CZI has made its largest commitments through the Chan Zuckerberg Biohub, a collaborative research center in San Francisco focused on infectious disease, cell biology, and bioengineering. CZI also funds the Chan Zuckerberg Initiative Science division, which builds open-source software tools for biomedical researchers. In education, CZI has invested in personalized learning platforms and supported school districts implementing technology-driven instruction. In community and justice, the organization has funded criminal justice reform, affordable housing, and immigration policy initiatives.

CZI’s investment portfolio is managed to support these programmatic activities while growing the endowment over time. The portfolio includes public equities (including the remaining Meta shares), private equity, venture capital, and impact-oriented investments.

Private Markets Approach

CZI’s private markets activity reflects its position at the intersection of Silicon Valley technology and large-scale philanthropy. The organization makes direct venture capital investments in early-stage and growth-stage companies whose products or services align with its mission areas, and also commits capital to external funds.

In the health and science domain, CZI has invested in companies developing biomedical research tools, diagnostic technologies, and computational biology platforms. These investments complement the organization’s grantmaking to the Biohub and its internal software development efforts, which include tools like cellxgene (a platform for single-cell genomics data) and napari (an image visualization tool for microscopy).

In education, CZI made a notable early investment in Summit Learning, a personalized learning platform developed in partnership with Summit Public Schools. The organization has continued to explore investments in education technology companies that align with its vision of student-centered learning.

CZI has also been active in affordable housing, making direct investments in housing development projects and committing capital to funds focused on preserving and expanding affordable housing stock in the San Francisco Bay Area and beyond.

The organization’s internal technology team, which numbers in the hundreds of engineers and scientists, gives CZI an unusual capacity to evaluate technology-driven investment opportunities. Fund managers seeking engagement should understand that CZI’s team brings deep technical expertise to investment evaluation, particularly in software, data science, and biomedical technology. Strategies that leverage technology to address systemic challenges in health, education, or housing are most likely to align with CZI’s investment mandate.